Proinsulin levels and the proinsulin:C-peptide ratio complement autoantibody measurement for predicting type 1 diabetes

Diabetologia

Volumn 48, Issue 11, 2005, Pages 2322-2329

  Truyen, I ^a   De Pauw, P ^a   Jorgensen P N ^b   Van Schravendijk, C ^a   Ubani, O ^a   Decochez, K ^a   Vandemeulebroucke, E ^a   Weets, I ^a   Mao, R ^a   Pipeleers, D G ^a   Gorus, F K ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b NOVO NORDISK A S   (Denmark)

Author keywords

C peptide; HLA DQ; IA 2 antibodies; Islet antibodies; Prediction; Proinsulin; Type 1 diabetes

Indexed keywords

C PEPTIDE; PROINSULIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC RISK; GENOTYPE; HUMAN; IMMUNOGENETICS; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEROCONVERSION; SEX RATIO;

ADULT; AUTOANTIBODIES; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HLA-DQ ANTIGENS; HORMONES; HUMANS; INFANT; INFANT, NEWBORN; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PEDIGREE; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; PROINSULIN;

EID: 27744498867     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1959-0     Document Type: Article

References (45)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
2. Notkins AL, Lernmark Å (2001) Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 108:1247-1252
3. Bingley PJ, Bonifacio E, Gale EAM (1993) Can we really predict IDDM? Diabetes 42:213-220
4. Gorus FK, Goubert P, Semakula C et al (1997) IA-2A-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40:95-99
5. Verge CF, Gianani R, Kawasaki E et al (1996) Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA 512 bdc/IA-2 autoantibodies. Diabetes 41:926-933
6. Kulmala P, Savola K, Petersen JS et al (1996) Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. J Clin Invest 101:327-336
7. Gorus FK, Pipeleers DG, the Belgian Diabetes Registry (2001) Prospects for predicting and stopping the development of type 1 diabetes. Best Pract Res Clin Endocrinol Metab 15:371-389
8. European Nicotinamide Diabetes Intervention Trial (ENDIT) Group (2004) European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925-931
9. Diabetes Prevention Trial - Type 1 Study Group (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685-1691
10. Decochez K, De Leeuw IH, Keymeulen B et al (2002) IA-2 autoantibodies predict impending Type É diabetes in siblings of patients. Diabetologia 45:1658-1666
11. Decochez K, Truyen I, Van der Auwera B et al (2005) Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing Type 1 diabetes. Diabetologia 48:687-694
12. Røder ME, Knip M, Hartling SG, Karjalainen J, Åkerblom HK, Binder C, the Childhood Diabetes in Finland Study Group (1994) Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. J Clin Endocrinol Metab 79:1570-1575
13. Røder ME, Porte DJ, Schwartz RS, Kahn SE (1998) Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:604-608
14. Hartling SG, Lindgren F, Dahlqvist G, Persson B, Binder C (1989) Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes 38:1271-1274
15. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS (1985) First-degree relatives of patients with type 1 diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med 313:461-464
16. Lo SSS, Hawa M, Beer SF, Pyke DA, Leslie RDG (1992) Altered islet beta-cell function before onset of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:277-282
17. Robert JJ, Deschamps I, Chevenne D, Roger M, Mogenet A, Boitard C (1991) Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type 1 diabetes in 220 juvenile first-degree relatives of diabetic patients. Diabetes Care 14:718-723
18. + relatives. The ICARUS Data Set. Diabetes 45:1720-1728
19. Bingley PJ, Colman P, Eisenbarth GS et al (1992) Standardization of IVGTT to predict IDDM. Diabetes Care 15:1313-1316
20. Hedstrand H, Boberg J (1975) Statistical analysis of the reproducibility of the intravenous glucose tolerance test and the serum insulin response to this test in the middle-aged men. Scand J Clin Lab Invest 35:331-337
21. Snorgaard O, Hartling SG, Binder C (1990) Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33:36-42
22. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057
23. Vandewalle CL, Coeckelberghs MI, De Leeuw IH et al (1997) Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry. Diabetes Care 20:1556-1561
24. Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK, the Belgian Diabetes Registry (1993) Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB* 0302 haplotype at clinical onset of Type I (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. Diabetologia 36:1155-1162
25. Decochez K, Tits J, Coolens J-L et al (2000) High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of insulin-requiring type 1 diabetes presenting before age 40 years. Diabetes Care 23:838-844
26. Van der Auwera B, Schuit FC, Lyaruu I et al (1995) Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. J Clin Endocrinol Metab 80:2567-2573
27. Kjems LL, Røder ME, Dinesen B, Hartling SG, Jørgensen PN, Binder C (1993) Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 39:2146-2150
28. Orban T, Kent SC, Malik P et al (2001) Heterophile antibodies indicate progression of autoimmunity in human type 1 diabetes mellitus before clinical onset. Autoimmunity 34:247-264
29. Heaton DA, Millward BA, Gray P et al (1987) Evidence of beta cell dysfunction which does not lead on to diabetes: a study of identical twins of insulin dependent diabetics. BMJ 294:145-146
30. Heaton DA, Millward BA, Gray IP et al (1988) Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients. Diabetologia 31:182-184
31. Lindgren FA, Hartling SG, Persson BE et al (1993) Proinsulin levels in newborn siblings of type 1 (insulin-dependent) diabetic children and their mothers. Diabetologia 36:560-563
32. Hartling SG, Knip M, Røder ME et al (1997) Longitudinal study of fasting proinsulin in 148 siblings of patients with insulin-dependent diabetes mellitus. Eur J Endocrinol 137:490-494
33. Spinas GA, Snorgaard O, Hartling SG, Oberholzer M, Berger W (1992) Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients. Diabetes Care 15:632-637
34. Hartling SG, Røder ME, Dinesen B, Binder C (1996) Proinsulin, C-peptide and insulin in normal subjects during an 8-h hyperglycaemic clamp. Eur J Endocrinol 134:197-200
35. Hostens K, Ling Z, Van Schravendijk C, Pipeleers DG (1999) Prolonged exposure of human beta cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine. J Clin Endocrinol Metab 84:1386-1390
36. Ling Z, Pipeleers DG (1996) Prolonged exposure of human beta; cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation. J Clin Invest 98:2805-2812
37. Kostens K, Pavlovic D, Zambre Y et al (1999) Exposure of human islets to cytokines can result in disproportionately elevated proinsulin release. J Clin Invest 104:67-72
38. Ling Z, Van de Casteele M, Eizirik DL, Pipeleers DG (2000) Interleukin-1β-induced alteration in a β-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. Diabetes 49:340-345
39. Fourlanos S, Narendran P, Byrnes GB et al (2004) Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661-1667
40. Snorgaard O, Kjems LL, Røder ME, Hartling SG, Dinesen B, Binder C (1996) Proinsulin immunoreactivity in recent-onset IDDM: the significance of insulin antibodies and insulin autoantibodies. Diabetes Care 19:146-150
41. Hummel M, Williams AJK, Norcross A et al (2001) Proinsulin-specific autoantibodies are relatively infrequent in young offspring with pre-type 1 diabetes. Diabetes Care 24:1843-1844
42. Yu J, Yu L, Bugawan TL et al (2000) Transient anti-islet autoantibodies: infrequent occurrence and lack of association with "genetic" risk factors. J Clin Endocrinol Metab 85:2421-2428
43. Savola K, Läärä E, Vähäsalo P, Kulmala P, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group (2001) Dynamic pattern of disease-associated autoantibodies in siblings of children with type 1 diabetes: a population based study. Diabetes 50:2625-2632
44. Gorus FK, Vandewalle CL, Dorchy H, Van Crombrugge P, Schuit FC, Pipeleers DG (1994) Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DQA1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry. J Clin Endocrinol Metab 78:1172-1178
45. Elahi D (1996) In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance. Diabetes Care 19:278-286